Yr 4 & 5 of a randomised controlled trial of an intensive intervention to reduce smoking among pregnant Indigenous women

四年级

基本信息

  • 批准号:
    nhmrc : 510771
  • 负责人:
  • 金额:
    $ 21.65万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2008
  • 资助国家:
    澳大利亚
  • 起止时间:
    2008-01-01 至 2009-12-31
  • 项目状态:
    已结题

项目摘要

Rates of smoking in pregnancy are significantly higher among Indigenous women than other Australian women (65% vs 20%). This application is to continue the first ever trial of an intensive program of smoking cessation advice provided to women and their ma
土著妇女怀孕期间的吸烟率明显高于其他澳大利亚妇女(65%对20%)。这项申请是为了继续向妇女及其丈夫提供戒烟建议的密集计划的首次试验

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

A/Pr Kathryn Panaretto其他文献

A/Pr Kathryn Panaretto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('A/Pr Kathryn Panaretto', 18)}}的其他基金

A randomised controlled trial of a high intensity intervention to reduce smoking among pregnant Indigenous women
一项高强度干预减少土著孕妇吸烟的随机对照试验
  • 批准号:
    nhmrc : 320851
  • 财政年份:
    2005
  • 资助金额:
    $ 21.65万
  • 项目类别:
    NHMRC Project Grants
Trichomonas vaginalis: prevalence in an urban indigenous population and validation of new assays
阴道毛滴虫:城市土著人群中的患病率和新检测方法的验证
  • 批准号:
    nhmrc : 216706
  • 财政年份:
    2002
  • 资助金额:
    $ 21.65万
  • 项目类别:
    NHMRC Project Grants

相似海外基金

Memory Reshaping for Depression: A Remote Digital Randomised Controlled Feasibility Trial
抑郁症记忆重塑:远程数字随机控制可行性试验
  • 批准号:
    MR/Y008545/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Research Grant
ExtraCECI: A cluster randomised controlled trial of community-based person-centred enhanced care for people with HIV/AIDS in Ghana
ExtraCECI:一项以社区为基础、以人为本的强化对加纳艾滋病毒/艾滋病患者护理的整群随机对照试验
  • 批准号:
    MR/Y019865/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Research Grant
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
对晚期癌症患者进行有针对性的早期姑息治疗 (STEP2) 进行现场和虚拟症状筛查的随机对照试验
  • 批准号:
    490098
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Operating Grants
Sedation Practice in Intensive Care Evaluation: Early Sedation with Dexmedetomidine in Older Ventilated Critically Ill Patients (SPICE-IV): A Randomised Double-Blind Placebo-Controlled Trial
重症监护评估中的镇静实践:老年通气危重患者早期使用右美托咪定镇静 (SPICE-IV):一项随机双盲安慰剂对照试验
  • 批准号:
    477888
  • 财政年份:
    2023
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Operating Grants
Eliciting and incorporating patients' opinions about missing data in randomised controlled trials
征求并纳入患者对随机对照试验中缺失数据的意见
  • 批准号:
    2755760
  • 财政年份:
    2022
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Studentship
MICA: Can interferon gamma prevent infection in critically ill patients at highest risk? A phase II randomised controlled trial.
MICA:γ 干扰素能否预防高风险危重患者的感染?
  • 批准号:
    MR/X004929/1
  • 财政年份:
    2022
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Research Grant
MICA: A randomised, double blind, controlled mechanistic study of obinutuzumab versus rituximab in ANCA-associated vasculitis (ObiVas)
MICA:一项关于 obinutuzumab 与利妥昔单抗治疗 ANCA 相关血管炎 (ObiVas) 的随机、双盲、对照机制研究
  • 批准号:
    MR/W015544/1
  • 财政年份:
    2022
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Research Grant
Intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine plus dihydroartemisinin-piperaquine to reduce adverse pregnancy outcomes and prevent malaria in Papua New Guinea: a randomised controlled trial
在巴布亚新几内亚,用磺胺多辛-乙胺嘧啶加双氢青蒿素-哌喹对妊娠期进行间歇性预防治疗,以减少不良妊娠结局并预防疟疾:一项随机对照试验
  • 批准号:
    nhmrc : 2000780
  • 财政年份:
    2022
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
Personalized integrated COgnitive-Sensory-MOtor training(iCOSMO) intervention to improve arm and hand function after chronic stroke: a pilot randomised controlled trial
个性化综合认知-感觉-运动训练(iCOSMO)干预以改善慢性中风后手臂和手部功能:一项试点随机对照试验
  • 批准号:
    460604
  • 财政年份:
    2022
  • 资助金额:
    $ 21.65万
  • 项目类别:
A novel placebo-based intervention for migraine: Randomised controlled trial
一种新颖的基于安慰剂的偏头痛干预措施:随机对照试验
  • 批准号:
    474000
  • 财政年份:
    2022
  • 资助金额:
    $ 21.65万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了